A Comprehensive Review on Pharmacological and Therapeutic Uses of Azadirachta Indica in the Treatment of Various Diseases

Year : 2025 | Volume : 15 | Issue : 01 | Page : 14-25
    By

    Anshul Thakur,

  • Balwinder Singh,

  • Seema Thakur,

  • Vinod Kumar Gauttam,

  1. Assistant Professor, Department of Pharmacology, Shiva Institute of Pharmacy, Chandpur, Bilaspur, Himachal Pradesh, India
  2. Assistant Professor, Department of Pharmaceutical Sciences, Amritsar Group of Colleges, Amritsar, Punjab, India
  3. Assistant Professor, Department of Pharmaceutics, Shiva Institute of Pharmacy, Chandpur, Bilaspur, Himachal Pradesh, India
  4. Principal, Shiva Institute of Pharmacy, Chandpur, Bilaspur, Himachal Pradesh, India

Abstract

In ancient medicine, the majority of illnesses were treated with plants and phyto-compounds. The most beneficial traditional medicinal plant is Azadirachta indica (Neem). In Ayurveda, it has several therapeutic effects. One of the most adaptable medicinal herbs, it exhibits a broad range of biological action. It possesses medicinal qualities, including anti-microbial, and high efficacy and safety agents. The biologically active components of this plant have a wide range of uses. The neem tree may be used inexpensively because each portion has some therapeutic value. These substances are a part of the class of natural products known as triterpenoids. The review contains all the information about various diseases that are being treated with the help of the neem plant. The therapeutic and potential uses of neem tree for future studies are discussed as well.

Keywords: Azadirachta indica, Quercetin, anti-microbial, Newcastle Disease, Rheumatoid Arthritis.

[This article belongs to Research and Reviews: A Journal of Pharmacology ]

How to cite this article:
Anshul Thakur, Balwinder Singh, Seema Thakur, Vinod Kumar Gauttam. A Comprehensive Review on Pharmacological and Therapeutic Uses of Azadirachta Indica in the Treatment of Various Diseases. Research and Reviews: A Journal of Pharmacology. 2025; 15(01):14-25.
How to cite this URL:
Anshul Thakur, Balwinder Singh, Seema Thakur, Vinod Kumar Gauttam. A Comprehensive Review on Pharmacological and Therapeutic Uses of Azadirachta Indica in the Treatment of Various Diseases. Research and Reviews: A Journal of Pharmacology. 2025; 15(01):14-25. Available from: https://journals.stmjournals.com/rrjop/article=2025/view=194786



Browse Figures

References

1. Lakshmi, T., et al., Azadirachta indica: A herbal panacea in dentistry–An update. Pharmacognosy reviews, 2015. 9(17):
p. 41-4 doi: 10.4103/0973-7847.156337.
2. Mehmood, M.D., et al., Antiviral activity and its prospective mechanism of action on Newcastle disease virus using crude extract of four medicinal plants. World Journal of Pharmaceutical Research, 2018. 7:(18) p. 130-141.
3. Rahmani, A., et al., Pharmacological and therapeutic potential of neem (Azadirachta indica). Pharmacognosy Reviews, 2018. 12(24): p. 250-255.
4. Mahmood, M.S., et al., Evaluation of antiviral activity of Azadirachta indica (Neem) bark extract against Newcastle disease virus. Pakistan Veterinary Journal, 2018. 38(1): p. 25-28.
5. Uchegbu, M., et al., The grovving importance of neem (Azadirachta indica A. Juss) in agriculture, industry, medicine and Eenvironment: A review. Research Journal of Medicinal Plant, 2011. 5(3): p. 230-245.
6. Kumar, D., A. Rahal, and J.K. Malik, Neem extract, in Nutraceuticals. 2016, Elsevier. p. 585-597 https://doi.org/10.1016/B978-0-12-802147-7.00043-7 .
7. Natarajan, V., P. Venugopal, and T. Menon, Effect of Azadirachta indica (neem) on the growth pattern of dermatophytes. Indian journal of medical microbiology, 2003. 21(2): p. 98-101.
8. Singh, P. and M. Tiwari, Review on Azadirachta Indica. Int J Pharma Life Sci, 2021. 2(1 Part A): p. 28-33 DOI: 10.33545/27072827.2021.v2.i1a.24 .
9. Oli, B. and D. Gautam, Medicinal value of Azadirachta indica: A review. Modern Phytomorphology, 2022. 15(6).

10. Alzohairy, M.A., Therapeutics role of Azadirachta indica (Neem) and their active constituents in diseases prevention and treatment. Evidence-Based Complementary and Alternative Medicine, 2016. 2016.
11. Maithani, A., et al., Azadirachta indica (neem) leaf: A review. Journal of Pharmacy Research, 2011. 4(6): p. 1824-1827.
12. Dash, S.P., S. Dixit, and S. Sahoo, Phytochemical and biochemical characterizations from leaf extracts from Azadirachta Indica: an important medicinal plant. Biochem Anal Biochem, 2017. 6(323): p. 2161-1009.1000323.
13. Singh, B., D. Pandya, and A. Mankad, A review on different pharmacological & biological activities of Azadirachta indica A. Jusm. and Melia azedarach L. L. J Plant Sci Res, 2020. 36(1-2): p. 53-59.
14. Okafor, P.C., E.E. Ebenso, and U.J. Ekpe, Azadirachta indica extracts as corrosion inhibitor for mild steel in acid medium. Int. J. Electrochem. Sci, 2010. 5(7): p. 978-993.
15. Sithisarn, P., R. Supabphol, and W. Gritsanapan, Antioxidant activity of Siamese neem tree (VP1209). Journal of Ethnopharmacology, 2005. 99(1): p. 109-112.
16. Shukla, V., M.D. Khurshid, and B. Kumar, A Review on Phytochemistry and Pharmacological Activity of Azadirachta indica (Neem). Int. J. Pharm. Biol. Sci, 2020. 10: p. 172-180.
17. Miller, P.J., E.L. Decanini, and C.L. Afonso, Newcastle disease: evolution of genotypes and the related diagnostic challenges. Infection, genetics and evolution, 2010. 10(1): p. 26-35.
18. Seal, B.S., D.J. King, and H.S. Sellers, The avian response to Newcastle disease virus. Developmental & Comparative Immunology, 2000. 24(2-3): p. 257-268.
19. Gueye, E., Newcastle disease in family poultry: prospects for its control through ethnoveterinary medicine. Livestock research for rural development, 2002. 14(5): p. 80-91.
20. Yusoff, K. and W.S. Tan, Newcastle disease virus: macromolecules and opportunities. Avian Pathology, 2001. 30(5): p. 439-455.
21. Song, H., et al., Application of Newcastle disease virus in the treatment of colorectal cancer. World Journal of Clinical Cases, 2019. 7(16): p. 2143.
22. Cattoli, G., et al., Newcastle disease: a review of field recognition and current methods of laboratory detection.
Journal of veterinary diagnostic investigation, 2011. 23(4): p. 637-656.
23. Dortmans, J.C., et al., Virulence of Newcastle disease virus: what is known so far? Veterinary research, 2011. 42(1): p. 1-11.
24. Connaris, H., et al., Probing the sialic acid binding site of the hemagglutinin-neuraminidase of Newcastle disease virus: identification of key amino acids involved in cell binding, catalysis, and fusion. Journal of virology, 2002. 76(4): p.
1816-1824.
25. Burman, B., G. Pesci, and D. Zamarin, Newcastle disease virus at the forefront of cancer immunotherapy. Cancers, 2020. 12(12): p. 3552.
26. Choi, K.-S., Newcastle disease virus vectored vaccines as bivalent or antigen delivery vaccines. Clinical and Experimental Vaccine Research, 2017. 6(2): p. 72-82.
27. Mohamed Amin, Z., et al., Evaluation of a recombinant Newcastle disease virus expressing human IL12 against human breast cancer. Scientific reports, 2019. 9(1): p. 1-10.
28. Mohanambal, K., et al., Evaluation of immunopotentiating effect of medicinal plant products in commercial layer flock vaccinated against Newcastle disease. Indian Journal of Animal Research, 2018. 52(9): p. 1343-1346.
29. Kwoh, C., et al., American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 update. Arthritis & Rheumatology, 2002. 46(2): p. 328-346.
30. Jalil, S.F., et al., Rheumatoid arthritis: what have we learned about the causing factors? Pakistan journal of pharmaceutical sciences, 2016. 29(2).
31. Tanaka, Y., Human mesenchymal stem cells as a tool for joint repair in rheumatoid arthritis. Clin Exp Rheumatol, 2015.
33(4 Suppl 92): p. S58-62.
32. Chauhan, K., et al., Continuing Education Activity. StatPearls [Internet]; Treasure Island (FL): StatPearls Publishing: Mountain View, CA, USA, 2021.
33. Guo, Q., et al., Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone research, 2018. 6(1): p. 15.

34. Etzel, C.J., et al., Genome-wide meta-analysis for rheumatoid arthritis. Human genetics, 2006. 119: p. 634-641.
35. Derksen, V., T. Huizinga, and D. Van Der Woude. The role of autoantibodies in the pathophysiology of rheumatoid arthritis. in Seminars in immunopathology. 2017. Springer.
36. Scherer, H.U., T. Häupl, and G.R. Burmester, The etiology of rheumatoid arthritis. Journal of autoimmunity, 2020. 110:
p. 102400.
37. Malmström, V., A.I. Catrina, and L. Klareskog, The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting. Nature Reviews Immunology, 2017. 17(1): p. 60-75.
38. Smolen, J., D. Aletaha, and I. McInnes, Therapies for bone R. Lancet, 2016: p. 30173-30178.
39. Gerlag, D.M., et al., EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis. Annals of the rheumatic diseases, 2012. 71(5): p. 638-641.
40. Tembe-Fokunang, E., et al., The potential pharmacological and medicinal properties of neem (Azadirachta indica A. Juss) in the drug development of phytomedicine. Journal of Complementary and Alternative Medical Research, 2019. 7(1): p. 1-18.
41. Cui, X., et al., Evaluation of antiarthritic activity of nimbolide against Freund’s adjuvant induced arthritis in rats.
Artificial cells, nanomedicine, and biotechnology, 2019. 47(1): p. 3391-3398.
42. Kang, J.J., et al., Comparative anti-inflammatory effects of anti-arthritic herbal medicines and Ibuprofen. Natural Product Communications, 2014. 9(9): p. 1934578X1400900932.
43. Benelli, G., et al., Bluetongue outbreaks: looking for effective control strategies against Culicoides vectors. Research in Veterinary Science, 2017. 115: p. 263-270.
44. Sparkenbaugh, E. and R. Pawlinski, Interplay between coagulation and vascular inflammation in sickle cell disease.
British Journal of Haematology, 2013. 162(1): p. 3-14.
45. Parise, L.V. and N. Berliner, Sickle cell disease: challenges and progress. Blood, The Journal of the American Society of Hematology, 2016. 127(7): p. 789-789.
46. Salinas Cisneros, G. and S.L. Thein, Recent advances in the treatment of sickle cell disease. Frontiers in physiology, 2020. 11: p. 435.
47. Tisdale, J.F., S.L. Thein, and W.A. Eaton, Treating sickle cell anemia. Science, 2020. 367(6483): p. 1198-1199.
48. Djote, W., et al., Antisickling, Antioxidant Properties, Fatty Acids and Vitamin E Compositions of Azadirachta Indica J.
Seed Oil Used to Manage Sickle Cell Disease (SCD) in North Cameroon J Nutr Food Lipid Sci, 2020. 1: p. 86-93.
49. Verma, D., M. Sahu, and K. Harris, ANTISICKLING PROPERTIES OF AZADIRACHTA INDICA A. JUSS LEAVES, FRUITS, AND STEM EXTRACTS. 2021.
50. Elumalai, P. and J. Arunakaran, Review on molecular and chemopreventive potential of nimbolide in cancer. Genomics & informatics, 2014. 12(4): p. 156-164.
51. Hassanpour, S.H. and M. Dehghani, Review of cancer from perspective of molecular. Journal of cancer research and practice, 2017. 4(4): p. 127-129.
52. Alyasiri, N.S., et al., PTEN-mediated AKT activation contributes to the reduced apoptosis among Indian oral squamous cell carcinoma patients. Journal of cancer research and clinical oncology, 2012. 138: p. 103-109.
53. Aizawa, K., et al., Tobacco carcinogen induces both lung cancer and non‐alcoholic steatohepatitis and hepatocellular carcinomas in ferrets which can be attenuated by lycopene supplementation. International journal of cancer, 2016. 139(5): p. 1171-1181.
54. Mahapatra, S., et al., Novel molecular targets of Azadirachta indica associated with inhibition of tumor growth in prostate cancer. The AAPS journal, 2011. 13: p. 365-377.
55. Moga, M.A., et al., An overview on the anticancer activity of Azadirachta indica (Neem) in gynecological cancers.
International journal of molecular sciences, 2018. 19(12): p. 3898.
56. Rahmani, A.H., et al., Therapeutic implications of black seed and its constituent thymoquinone in the prevention of cancer through inactivation and activation of molecular pathways. Evidence-Based Complementary and Alternative Medicine, 2014. 2014.

57. Batra, N., et al., Exploring the therapeutic potential of Neem (Azadirachta Indica) for the treatment of prostate cancer: a literature review. Annals of translational medicine, 2022. 10(13).
58. Morris, J., et al., The highly pure neem leaf extract, SCNE, inhibits tumorigenesis in oral squamous cell carcinoma via disruption of pro-tumor inflammatory cytokines and cell signaling. Frontiers in oncology, 2019. 9: p. 890.
59. Shin, S.-S., et al., Nimbolide represses the proliferation, migration, and invasion of bladder carcinoma cells via Chk2- mediated G2/M phase cell cycle arrest, altered signaling pathways, and reduced transcription factors-associated MMP-9 expression. Evidence-Based Complementary and Alternative Medicine, 2019. 2019.
60. Peeling, R.W., et al., Syphilis (Primer). Nature Reviews: Disease Primers, 2017. 3(1).
61. Oliver, S.E., et al., Increases in ocular syphilis—North Carolina, 2014–2015. Clinical Infectious Diseases, 2017. 65(10):
p. 1676-1682.
62. Tiecco, G., et al., A 2021 update on syphilis: Taking stock from pathogenesis to vaccines. Pathogens, 2021. 10(11): p. 1364.
63. Streight, K.L., R.M. Paranal, and D.M. Musher, The oral manifestations of syphilitic disease: a case report. Journal of medical case reports, 2019. 13: p. 1-3.
64. Ho, E.L. and S.A. Lukehart, Syphilis: using modern approaches to understand an old disease. The Journal of clinical investigation, 2011. 121(12): p. 4584-4592.
65. McIver, L.A. and M.S. Siddique, Continuing Education Activity. 2021, StatPearls Publishing, National Center for Biotechnology Information.
66. Moin, M.S., et al., Ethnomedicinal potential of widely used plant Azadirachta indica A. Juss: A comprehensive review.
The Journal of Phytopharmacology, 2021. 10(6): p. 456-467.
67. Omóbòwálé, T.O., et al., Antihypertensive effect of polyphenol-rich fraction of Azadirachta indica on Nω-Nitro-L- arginine methyl ester-induced hypertension and cardiorenal dysfunction. Drug research, 2019. 69(01): p. 12-22.
68. Singh, S., R. Shankar, and G.P. Singh, Prevalence and associated risk factors of hypertension: a cross-sectional study in urban Varanasi. International journal of hypertension, 2017. 2017.
69. Rahmawati, R. and B.V. Bajorek, Self-medication among people living with hypertension: a review. Family practice, 2017. 34(2): p. 147-153.
70. Oparil, S., et al., Hypertension (Primer). Nature Reviews: Disease Primers, 2018. 4(1): p. 18014.
71. Kawamoto, R., et al., Alcohol consumption is positively associated with handgrip strength among Japanese community-dwelling middle-aged and elderly persons. International Journal of Gerontology, 2018. 12(4): p. 294-298.
72. Unger, T., et al., 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension, 2020. 75(6): p. 1334-1357.
73. Shah, A.J., et al., Neem (Azadirachta indica) lowers blood pressure through a combination of Ca” channel blocking and endothelium-dependent muscarinic receptors activation. Int J Pharmacol, 2014. 10(8): p. 418-28.
74. Yarmohammadi, F., et al., The protective effect of Azadirachta indica (neem) against metabolic syndrome: A review.
Iranian Journal of Basic Medical Sciences, 2021. 24(3): p. 280.
75. Cummings, J.L. and G. Cole, Alzheimer disease. Jama, 2002. 287(18): p. 2335-2338.
76. Uwishema, O., et al., Is Alzheimer's disease an infectious neurological disease? A review of the literature. Brain and Behavior, 2022. 12(8): p. e2728.
77. Mayer, J., et al. A Soft-Correspondence Approach to Shape-based Disease Grading with Graph Convolutional Networks. in Geometric Deep Learning in Medical Image Analysis. 2022. PMLR.
78. Reitz, C., C. Brayne, and R. Mayeux, Epidemiology of Alzheimer disease. Nature Reviews Neurology, 2011. 7(3): p. 137- 152.
79. Skoog, I., R.N. Kalaria, and M.M. Breteler, Vascular factors and Alzheimer disease. Alzheimer Disease & Associated Disorders, 1999. 13: p. S106-S114.
80. Raghavendra, M., et al., Role of aqueous extract of Azadirachta indica leaves in an experimental model of Alzheimer's disease in rats. International Journal of Applied and Basic Medical Research, 2013. 3(1): p. 37.
81. Mayer-Davis, E.J., et al., ISPAD Clinical Practice Consensus Guidelines 2018: Definition, epidemiology, and classification of diabetes in children and adolescents. Pediatric diabetes, 2018. 19(Suppl 27): p. 7.

82. HM, K., Diabetes mellitus: the epidemic of the century World J. Diabetes, 2015. 6(6): p. 850.
83. Association, A.D., Diagnosis and classification of diabetes mellitus. Diabetes care, 2014. 37(Supplement_1): p. S81- S90.
84. Kaur, N., et al., Interplay between type 1 diabetes mellitus and celiac disease: implications in treatment. Digestive diseases, 2018. 36(6): p. 399-408.
85. Yaseen, G., et al., Traditional management of diabetes in Pakistan: ethnobotanical investigation from traditional health practitioners. Journal of ethnopharmacology, 2015. 174: p. 91-117.
86. Rameshrad, M., et al., Pharmacology of dipeptidyl peptidase-4 inhibitors and its use in the management of metabolic syndrome: a comprehensive review on drug repositioning. DARU Journal of Pharmaceutical Sciences, 2019. 27: p. 341- 360.
87. Rameshrad, M., et al., An overview of glucagon-like peptide-1 receptor agonists for the treatment of metabolic syndrome: A drug repositioning. Iranian Journal of Basic Medical Sciences, 2020. 23(5): p. 556.
88. Riyanti, S., A.G. Suganda, and E.Y. Sukandar, Dipeptidyl peptidase-IV inhibitory activity of some Indonesian medicinal plants. Asian Journal of Pharmaceutical and Clinical Research, 2016: p. 375-377.

Regular Issue Subscription Review Article
Volume 15
Issue 01
Received 13/01/2025
Accepted 16/01/2025
Published 21/01/2025
Total Visits: 111


My IP

PlumX Metrics